The Official pharmaceutical laboratories and their relevance to Brazil’s public health
DOI:
https://doi.org/10.3395/reciis.v5i1.512Keywords:
official pharmaceutical laboratories, public production of medicines, public health, pharmaceutical industryAbstract
This paper identifies the current portfolio of the Brazilian Network for the Public Production of Medicines (RBPPM) and evaluates the modernization and expansion of the Official Pharmaceutical Laboratories (OPLs) production capacity in the last seven years. Investments of about R$ 300 million have been made to expand the annual installed capacity from 5 to 16.6 billion Pharmaceutical Units1 (PUs). The work consisted of interviews, literature searches and queries to the database of the Official Laboratories Association, National Health Surveillance Agency (ANVISA), Ministry of Health (MS) and Ministry of Science and Technology (MCT). According to the RBPPM portfolio, 99% are similar drugs and the majority of the registers address hypertension and analgesia treatments. The laboratories structure can be considered national property, not only because they produce drugs neglected by the private industry but also because they serve as price regulators and have the potential to develop new pharmaceutical products and formulations. The leading Official Pharmaceutical Laboratories are skilled and competent both in human resources and infrastructure, causing OPLs to be strategic to the MH, thus contributing to the relevance in healthcare.Downloads
How to Cite
Issue
Section
License
Author’s rights: The author retains unrestricted rights over his work.
Rights to reuse: Reciis adopts the Creative Commons License, CC BY-NC non-commercial attribution according to the Policy on Open Access to Knowledge by Oswaldo Cruz Foundation. With this license, access, download, copy, print, share, reuse, and distribution of articles is allowed, provided that it is for non-commercial use and with source citation, granting proper authorship credits and reference to Reciis. In such cases, no permission is required from the authors or editors.
Rights of authors’s deposit / self-archiving: The authors are encouraged to deposit the published version, along with the link of their article in Reciis, in institutional repositories.